GHK
peptide · adjunctResearch use onlyGly-His-Lys · GHK tripeptide · glycyl-L-histidyl-L-lysine
GHK is an endogenous copper-binding tripeptide that acts as a gene-expression modulator, up- and down-regulating thousands of human genes to stimulate fibroblast collagen and glycosaminoglycan synthesis, tissue remodeling, and antioxidant/anti-inflammatory pathways.
Overview
GHK (Gly-His-Lys, MW 340.4) is a tripeptide naturally present in human plasma that declines with age. Free GHK avidly chelates copper(II) to form GHK-Cu, and the large majority of the published skin-regeneration and tissue-repair evidence is preclinical (in-vitro fibroblast cultures, animal wound models) and was generated on the GHK-Cu copper complex rather than on free copper-free GHK. Direct human clinical trials of the copper-free tripeptide are essentially absent. The GHK-Cu complex is tracked as a separate agent on this platform.
How it works
- Binds copper(II) with high affinity, forming GHK-Cu and participating in copper homeostasis.
- Modulates expression of a large fraction of the human genome, shifting toward DNA repair, antioxidant defense, and tissue remodeling.
- Stimulates dermal fibroblast synthesis of collagen, elastin, decorin, and glycosaminoglycans.
- Regulates MMPs and their inhibitors (TIMPs), balancing ECM synthesis and breakdown.
- Anti-inflammatory and antioxidant actions.
- Promotes angiogenesis and nerve outgrowth in preclinical wound models.
Cycling
Side effects
- Notes
No established human safety dataset for copper-free GHK as a standalone therapeutic. Most human exposure is topical GHK-Cu in cosmetics. Research use only; not an approved drug.
- Common
Research studies
Studies summarized for educational purposes only. Inclusion does not imply human use; referenced research was conducted in vitro, in animal models, or in regulated clinical trials.
GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration
Pickart L, Vasquez-Soltero JM, Margolina A. Biomed Res Int. 2015;2015:648108. View source ↗
This review synthesizes the molecular biology of GHK across multiple cellular systems relevant to dermal research. The authors describe the discovery of GHK in human plasma in 1973 at approximately 200 μg/L in young adults, declining to roughly 80 μg/L by age 60–80, and summarize the peptide's high affinity for Cu(II) which drives formation of the GHK-Cu complex in physiological conditions. Reported in vitro effects of GHK (both the free peptide and the copper complex) include modulation of extracellular matrix gene expression — collagen, elastin, glycosaminoglycan synthesis — alongside fibroblast proliferation and induction of antioxidant genes. The authors note that biological activity in most preclinical models is attributed to the copper-bound complex rather than the free peptide alone, and discuss the equilibrium between the two forms in biological media.
Researchers reviewed what is known about GHK in skin biology. GHK was discovered in human blood in 1973, and levels drop with age. The peptide on its own binds tightly to copper ions, and in most lab studies it is actually the copper-bound form (GHK-Cu) that does the work — switching on genes that build collagen and elastin, waking up the cells that produce these proteins, and turning on the cell's antioxidant defenses. The review explains that plain GHK and GHK-Cu exist in equilibrium in biological fluids depending on how much copper is present.
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Pickart L, Margolina A. Int J Mol Sci. 2018;19(7):1987. View source ↗
Using gene-expression datasets from the Broad Institute's Connectivity Map, the authors analyzed GHK's effect on the transcriptome of human cells. GHK exposure was associated with statistically significant modulation of more than 4,000 genes, with effects clustering around DNA repair pathways, ubiquitin-proteasome regulation, antioxidant defense, and inflammatory signaling. The authors discuss the relationship between the free peptide and the copper-bound complex, noting that GHK introduced into cell culture media containing trace copper will form GHK-Cu, complicating attribution of observed gene-expression changes to one form or the other.
Scientists used a large public database of gene activity to look at how GHK changes which genes are turned on or off in human cells. They found GHK affects thousands of genes — particularly ones involved in fixing DNA, recycling damaged proteins, calming inflammation, and protecting against oxidative damage. The authors point out that even when researchers add plain GHK to cells, copper already present in the growth medium can bind to it, so the observed effects may reflect the copper-bound form rather than the free peptide.
Verified citations
7 · PubMed-checked- GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin RegenerationreviewPMID 26236730 ↗
- Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene DatareviewPMID 29986520 ↗
- GHK and DNA: Resetting the Human Genome to HealthreviewPMID 25302294 ↗
- The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive healthreviewPMID 22666519 ↗
- The potential of GHK as an anti-aging peptidereviewPMID 35083444 ↗
- Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+preclinicalPMID 3169264 ↗
- Synergy of GHK-Cu and hyaluronic acid on collagen IV upregulation via fibroblast and ex-vivo skin testspreclinicalPMID 37062921 ↗
Bioavailability
- Oral
- Not established; expected GI degradation.
- Topical
- Primarily studied topically (usually as GHK-Cu); free GHK is small/hydrophilic with limited passive penetration.
- Systemic
- No validated human PK for the free tripeptide.
Storage & handling
- Lyophilized
Store lyophilized powder desiccated and protected from light; -20C typical.
- Reconstituted
Refrigerate at 2-8C and use within a short window; protect from light.
Used for
Legal / compounding
Legal status is a hard gate: non-compoundable or delisted agents cannot be filled and are blocked from protocol export. Keep 503A status current.